Skip to main content
. Author manuscript; available in PMC: 2014 May 19.
Published in final edited form as: J Cancer Ther. 2014 Jan;5(1):124–131. doi: 10.4236/jct.2014.51015

Figure 1.

Figure 1

Meta-Analysis of SYK Signature Gene Expression in B-lineage Leukemia/Lymphoma Patients Using the Oncomine Database. The most consistently discriminating anti-apoptotic genes, SYK, STAT3, and confirmed STAT3 target genes [11] were cross-referenced to the Oncomine™ Research Data Base (http://www.oncomine.org/) for leukemia and lymphoma studies. Each comparison was identified by a Database reference (From the top of the cluster figure: Alizadeh Lymphoma, Alizadeh Lymphoma, Rosenwald Lymphoma, Rosenwald Multi-cancer, Valk Leukemia, Alizadeh Lymphoma, Storz Lymphoma, Rosenwald Lymphoma, Alizadeh Lymphoma, Alizadeh Lymphoma, Storz Lymphoma, Rosenwald Multi-cancer, Rosenwald Multi-cancer, Storz Lymphoma, Haslinger Leukemia, Andersson Leukemia, Basso Lymphoma, Basso Lymphoma, Basso Lymphoma, Basso Lymphoma, Maia Leukemia, Basso Lymphoma, Basso Lymphoma) and details of the normal cells used in the fold difference calculations can be found on the website. We filtered fold difference relative to normal cells that showed P-values less than 0.05.